Related Experiment Video
Updated: Jul 8, 2025

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Forensic, legal, and clinical aspects of deaths associated with implanted cardiac devices
Jan M Federspiel1, Stefan Potente1, Karen B Abeln2
1Faculty of Medicine, Institute of Legal Medicine, Saarland University, Homburg, Germany.
Insights
Determining the cause of death in patients with implanted cardiac devices requires an interdisciplinary approach. This study proposes a workflow to differentiate deaths due to or with the device, aiding legal and clinical experts.
Area of Science:
- Forensic Pathology
- Cardiology
- Psychiatry
Background:
- Increasing prevalence of heart failure and implanted cardiac devices in aging populations presents diagnostic challenges.
- Co-occurrence of heart disease with mental health conditions, including suicidality, complicates death investigations.
- Accurate cause of death determination is crucial for quality assurance, therapeutic advancement, legal safety, and suicide prevention.
Purpose of the Study:
- To summarize psychiatric comorbidities and suicidality in patients with implanted cardiac devices.
- To provide essential information on device complications, malfunctions, and device-associated deaths, including manipulation.
- To outline legal and ethical considerations in investigating deaths of device carriers.
Main Methods:
- Review of existing literature on psychiatric comorbidities, suicidality, and implanted cardiac devices.
- Analysis of device complications, malfunctions, and device-associated deaths.
- Examination of legal and ethical frameworks relevant to death investigation.
Main Results:
- Implanted cardiac devices can be associated with psychiatric comorbidities and suicidality.
- Device malfunctions or manipulation can contribute to death, requiring careful investigation.
- An interdisciplinary approach involving legal medicine, clinicians, and law enforcement is necessary.
Conclusions:
- A proposed interdisciplinary assessment workflow can improve the diagnosis of deaths related to implanted cardiac devices.
- This workflow facilitates differentiation between death occurring with the device versus death caused by the device.
- Improved diagnostic accuracy supports quality improvement, legal accountability, and suicide prevention strategies.
Abstract:
As the population ages, the prevalence of heart failure and individuals wearing an implanted cardiac device is increasing. The combination of different underlying pathophysiologies and (the combination of) implanted cardiac devices can become a challenge with regard to the determination of cause and manner of death in such individuals. Additionally, heart disease is frequently associated with mental disease, ranging from anxiety and depression to suicidality and suicide (attempts). At the same time, the correct diagnosis of cause and manner of death is the basis for quality assurance, further therapeutic advances, legal safety, and suicide prevention. By that, an interdisciplinary field between legal medicine, clinicians, and law enforcement opens up. In this field, the different participants can simultaneously benefit from and need each other. For example, legal medicine experts need investigatory results and clinical expertise for the interpretation of readout data of implanted cardiac devices in order to correctly determine the cause of death. A correctly determined cause of death can assist law enforcement and help clinicians to further improve various therapeutic approaches based on correct mortality data collection. In addition, it is the basis for identification of suicides of device carriers, allowing psychological and psychiatric experts to better understand the burden of mental disease in this particular cohort. Against this interdisciplinary background, this manuscript summarizes information about psychiatric comorbidities and suicidality while being on a device. Thereby, basic information on complications and malfunctions of implanted cardiac devices, device-associated deaths with particular emphasis on device manipulation is displayed as basic information needed for correct determination of the cause of death. Also, legal and ethical issues in this field are outlined. The final result is a proposal of an interdisciplinary assessment workflow for a conjoint approach to improve the diagnosis of deaths associated with implanted cardiac devices. It will allow for a differentiation between an individual who died with or due to the device.
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac Catheterization IV: Nursing Management

